Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Zocor 20mg


Contraindicated
Reduce the foetal levels of mevalonate (precursor of cholesterol biosynthesis)

Contraindicated
Zocor 20mg :
Type Medicine Authorised
Originator B
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory MSD
Manufacturer Algorithm Pharmaceutical Manufacturers
Manufacturing Type Under license from Merck and Co USA
Origin Lebanon
ATC C10AA01

Your comment will appear shortly after approval

Zocor 20mg :

Revision Date : 01/09/2015


Effect Frequency
Abdominal pain Rare
Alopecia Rare
ALT increased Rare
Anaemia Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Arthralgia (Pain joint) (Joint ache) Not known
Arthritis Not known
AST increased Rare
Asthenia Rare
Blood alkaline phosphatase increased Rare
Blood creatine phosphokinase increased Rare
Cephalea Rare
Cognitive impairment (Cognitive disturbance) Very rare
Constipation Rare
Depression Not known
Dermatomyositis Not known
Diarrhoea (Diarrhea) Rare
Dyspepsia Rare
Dyspnoea (dyspnea) Not known
Eosinophilia Not known
Erectile dysfunction Not known
erythrocyte sedimentation rate (ESR) increased Not known
Fasting hyperglycaemia Not known
Fever Not known
Flatulence Rare
Flushing Not known
Gamma-GT increased Rare
Glycosylated haemoglobin increased Not known
Hepatic failure (Hepatic insufficiency) (Liver failure) Very rare
Hepatitis Rare
Hypersensitivity reactions Rare
Immune-mediated necrotising myopathy Very rare
Insomnia Very rare
Interstitial pneumonitis Not known
Jaundice Rare
Lupus syndrome Not known
Malaise Not known
Memory impairment Very rare
Muscle cramps Rare
Myalgia Rare
Myopathy Rare
Myositis Rare
Nausea Rare
Neuropathy peripheral Rare
Pancreatitis Rare
Paraesthesia (paresthesia) Rare
Photosensitivity Not known
Polymyalgia rheumatica Not known
Pruritus Rare
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Rare
Rhabdomyolysis Rare
Skin rash Rare
Tendon rupture Not known
Tendonopathy Not known
Thrombocytopenia (Thrombopenia) Not known
Urticaria Not known
Vasculitides Not known
Vertigo Rare
Vomiting Rare

Different Units By MoH Code

Revision Date : 01/02/2016

Zocor 20mg  MoH 6728 :
Form Tablet
Package Size Box of 30
Strength 20mg
Storage Condition 15-30°C In the original container
Public Price 981981 L.L.
Stratum A2
NSSF ✔
Quarantine ✘
Reg. Number 97662/11
Submission date 01/01/2011
Registration Year 2012
Barcode 5285003471353


Price Comparison

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 30
● Public Price: 981981 LBP ( 981,981.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 32732,7 LBP ( 32,732.00 LBP )
● Pricing Date: 10/01/2024

● Country: Denmark
● Package Size: 98
● Public Price: 960.45 DKK ( 2,363,638.64 LBP )
● Pack size unit used: 98
● Cost/Unit: 9,8005 DKK ( 22,148.73 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Non Marketed

● Country: UK
● Package Size: 28
● Public Price: 29.69 GBP ( 598,276.36 LBP )
● Pack size unit used: 28
● Cost/Unit: 1,0604 GBP ( 20,150.77 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 28
● Public Price: 39.55 CHF ( 674,732.89 LBP )
● Pack size unit used: 28
● Cost/Unit: 1,4125 CHF ( 17,060.25 LBP )
● Exfactory Price: 20.16 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 30
● Public Price: 124 QAR ( 514,669.44 LBP )
● Pack size unit used: 30
● Cost/Unit: 4,1333 QAR ( 16,602.24 LBP )
● Pharmacy Price: 101.75626787387 QAR ( 422345.49518656 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 28
● Public Price: 91.5 AED ( 376,152.84 LBP )
● Pack size unit used: 28
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Pharmacy Price: 73.95 AED ( 304005.492 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 28's (14's Blister x 2)
● Public Price: 91.5 AED ( 376,152.84 LBP )
● Pack size unit used: 28
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Pharmacy Price: 73.95 AED ( 304005.492 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: KSA
● Package Size: 28
● Public Price: 83.1 SAR ( 334,924.58 LBP )
● Pack size unit used: 28
● Cost/Unit: 2,9679 SAR ( 8,060.76 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Norway
● Package Size: 98
● Public Price: 351.5 NOK ( 608,189.91 LBP )
● Pack size unit used: 98
● Cost/Unit: 3,5867 NOK ( 5,190.81 LBP )
● Pharmacy Price: 247.22 NOK ( 427757.3494 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Argentina
● Package Size: 30
● Public Price: 869.35 ARS ( 156,804.66 LBP )
● Pack size unit used: 30
● Cost/Unit: 28,9783 ARS ( 5,050.36 LBP )
● Reference: Ministerio de Salud
● Pricing Date: 13/05/2019
● Type: Medicine Authorised

● Country: Oman
● Package Size: 28
● Public Price: 9.78 OMR ( 384,358.89 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,3493 OMR ( 0.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 30
● Public Price: 6.23 JOD ( 132,949.38 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,2077 JOD ( 0.00 LBP )
● Pharmacy Price: 4.75 JOD ( 101365.9025 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 28
● Public Price: 8.92 BHD ( 357,877.27 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,3186 BHD ( 0.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 30
● Public Price: 12.08 EUR ( 222,031.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,4027 EUR ( 0.00 LBP )
● Pharmacy Price: 5.08 EUR ( 93370.654 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Germany
● Package Size: 100
● Public Price: 54.72 EUR ( 1,005,756.34 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,5472 EUR ( 0.00 LBP )
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: 28
● Public Price: 7.62 KWD ( 377,724.01 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2721 KWD ( 0.00 LBP )
● Pharmacy Price: 6.44 KWD ( 319231.3152 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 28
● Public Price: 8.27 EUR ( 152,003.01 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2954 EUR ( 0.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 10
● Public Price: 3.73 EUR ( 68,557.59 LBP )
● Pack size unit used: 10
● Cost/Unit: 0,373 EUR ( 0.00 LBP )
● Exfactory Price: 2.58 EUR
● Pharmacy Price: 2.71 EUR ( 49809.9355 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 28
● Public Price: 23.47 TRY ( 45,078.59 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Finland
● Package Size: 98
● Public Price: 45.28 EUR ( 832,248.66 LBP )
● Pack size unit used: 98
● Cost/Unit: 0,462 EUR ( 0.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 28UNITA
● Public Price: 7.62 EUR ( 140,055.98 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2721 EUR ( 0.00 LBP )
● Pricing Date: 15/01/2021
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 28
● Public Price: 3.47 EUR ( 63,778.77 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,1239 EUR ( 0.00 LBP )
● Exfactory Price: 3 EUR
● Pricing Date: 09/10/2020
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 28 TABS
● Public Price: 10.19 EUR ( 187,292.71 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,3639 EUR ( 0.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 84
● Public Price: 13.78 EUR ( 253,277.09 LBP )
● Pack size unit used: 84
● Cost/Unit: 0,164 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: France
● Package Size: 28
● Public Price: 5.97 EUR ( 109,728.90 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Tunisia
● Package Size: 28
● Public Price: 88.5 TND ( 0.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 3,1607 TND ( 0.00 LBP )
● Pricing Date: 04/02/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Homozygous familial hypercholesterolemia :
● Cost/Unit: 32732,7 LBP ( 32,732.00 LBP )
● Cost/Day: 65465,4 LBP ( 65,465.00 LBP )
● Cost/Month: 1963962 LBP ( 1,963,962.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 32732,7 LBP ( 32,732.00 LBP )
● Cost/Day: 32732,7 LBP ( 32,732.00 LBP )
● Cost/Month: 981981 LBP ( 981,981.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 32732,7 LBP ( 32,732.00 LBP )
● Cost/Day: 32732,7 LBP ( 32,732.00 LBP )
● Cost/Month: 981981 LBP ( 981,981.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 9,8005 DKK ( 22,148.73 LBP )
● Cost/Day: 19,6 DKK ( 46,758.43 LBP )
● Cost/Month: 588 DKK ( 1,447,050.36 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 9,8005 DKK ( 22,148.73 LBP )
● Cost/Day: 9,8 DKK ( 22,148.73 LBP )
● Cost/Month: 294 DKK ( 723,525.18 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 9,8005 DKK ( 22,148.73 LBP )
● Cost/Day: 9,8 DKK ( 22,148.73 LBP )
● Cost/Month: 294 DKK ( 723,525.18 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 1,0604 GBP ( 20,150.77 LBP )
● Cost/Day: 2,12 GBP ( 40,301.54 LBP )
● Cost/Month: 63,6 GBP ( 1,269,498.51 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 1,0604 GBP ( 20,150.77 LBP )
● Cost/Day: 1,06 GBP ( 20,150.77 LBP )
● Cost/Month: 31,8 GBP ( 624,673.87 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 1,0604 GBP ( 20,150.77 LBP )
● Cost/Day: 1,06 GBP ( 20,150.77 LBP )
● Cost/Month: 31,8 GBP ( 624,673.87 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 1,4125 CHF ( 17,060.25 LBP )
● Cost/Day: 2,82 CHF ( 34,120.50 LBP )
● Cost/Month: 84,6 CHF ( 1,433,061.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 1,4125 CHF ( 17,060.25 LBP )
● Cost/Day: 1,41 CHF ( 17,060.25 LBP )
● Cost/Month: 42,3 CHF ( 716,530.50 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 1,4125 CHF ( 17,060.25 LBP )
● Cost/Day: 1,41 CHF ( 17,060.25 LBP )
● Cost/Month: 42,3 CHF ( 716,530.50 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 4,1333 QAR ( 16,602.24 LBP )
● Cost/Day: 8,27 QAR ( 33,204.48 LBP )
● Cost/Month: 248,1 QAR ( 1,029,338.88 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 4,1333 QAR ( 16,602.24 LBP )
● Cost/Day: 4,13 QAR ( 16,602.24 LBP )
● Cost/Month: 123,9 QAR ( 510,518.88 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 4,1333 QAR ( 16,602.24 LBP )
● Cost/Day: 4,13 QAR ( 16,602.24 LBP )
● Cost/Month: 123,9 QAR ( 510,518.88 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Cost/Day: 6,54 AED ( 24,665.76 LBP )
● Cost/Month: 196,2 AED ( 805,748.16 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Cost/Day: 3,27 AED ( 12,332.88 LBP )
● Cost/Month: 98,1 AED ( 402,874.08 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Cost/Day: 3,27 AED ( 12,332.88 LBP )
● Cost/Month: 98,1 AED ( 402,874.08 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Cost/Day: 6,54 AED ( 24,665.76 LBP )
● Cost/Month: 196,2 AED ( 805,748.16 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Cost/Day: 3,27 AED ( 12,332.88 LBP )
● Cost/Month: 98,1 AED ( 402,874.08 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 3,2679 AED ( 12,332.88 LBP )
● Cost/Day: 3,27 AED ( 12,332.88 LBP )
● Cost/Month: 98,1 AED ( 402,874.08 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 2,9679 SAR ( 8,060.76 LBP )
● Cost/Day: 5,94 SAR ( 20,151.90 LBP )
● Cost/Month: 178,2 SAR ( 717,407.64 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 2,9679 SAR ( 8,060.76 LBP )
● Cost/Day: 2,97 SAR ( 8,060.76 LBP )
● Cost/Month: 89,1 SAR ( 358,703.82 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 2,9679 SAR ( 8,060.76 LBP )
● Cost/Day: 2,97 SAR ( 8,060.76 LBP )
● Cost/Month: 89,1 SAR ( 358,703.82 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 3,5867 NOK ( 5,190.81 LBP )
● Cost/Day: 7,17 NOK ( 12,111.89 LBP )
● Cost/Month: 215,1 NOK ( 372,008.05 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 3,5867 NOK ( 5,190.81 LBP )
● Cost/Day: 3,59 NOK ( 5,190.81 LBP )
● Cost/Month: 107,7 NOK ( 185,138.89 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 3,5867 NOK ( 5,190.81 LBP )
● Cost/Day: 3,59 NOK ( 5,190.81 LBP )
● Cost/Month: 107,7 NOK ( 185,138.89 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 28,9783 ARS ( 5,050.36 LBP )
● Cost/Day: 57,96 ARS ( 10,281.09 LBP )
● Cost/Month: 1738,8 ARS ( 313,483.06 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 28,9783 ARS ( 5,050.36 LBP )
● Cost/Day: 28,98 ARS ( 5,050.36 LBP )
● Cost/Month: 869,4 ARS ( 156,741.53 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 28,9783 ARS ( 5,050.36 LBP )
● Cost/Day: 28,98 ARS ( 5,050.36 LBP )
● Cost/Month: 869,4 ARS ( 156,741.53 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,373 EUR ( 0.00 LBP )
● Cost/Day: 0,75 EUR ( 0.00 LBP )
● Cost/Month: 22,5 EUR ( 404,361.10 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,373 EUR ( 0.00 LBP )
● Cost/Day: 0,37 EUR ( 0.00 LBP )
● Cost/Month: 11,1 EUR ( 202,180.55 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,373 EUR ( 0.00 LBP )
● Cost/Day: 0,37 EUR ( 0.00 LBP )
● Cost/Month: 11,1 EUR ( 202,180.55 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2954 EUR ( 0.00 LBP )
● Cost/Day: 0,59 EUR ( 0.00 LBP )
● Cost/Month: 17,7 EUR ( 312,460.85 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2954 EUR ( 0.00 LBP )
● Cost/Day: 0,3 EUR ( 0.00 LBP )
● Cost/Month: 9 EUR ( 165,420.45 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2954 EUR ( 0.00 LBP )
● Cost/Day: 0,3 EUR ( 0.00 LBP )
● Cost/Month: 9 EUR ( 165,420.45 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,5472 EUR ( 0.00 LBP )
● Cost/Day: 1,09 EUR ( 18,380.05 LBP )
● Cost/Month: 32,7 EUR ( 588,161.60 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,5472 EUR ( 0.00 LBP )
● Cost/Day: 0,55 EUR ( 0.00 LBP )
● Cost/Month: 16,5 EUR ( 294,080.80 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,5472 EUR ( 0.00 LBP )
● Cost/Day: 0,55 EUR ( 0.00 LBP )
● Cost/Month: 16,5 EUR ( 294,080.80 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,4027 EUR ( 0.00 LBP )
● Cost/Day: 0,81 EUR ( 0.00 LBP )
● Cost/Month: 24,3 EUR ( 441,121.20 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,4027 EUR ( 0.00 LBP )
● Cost/Day: 0,4 EUR ( 0.00 LBP )
● Cost/Month: 12 EUR ( 220,560.60 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,4027 EUR ( 0.00 LBP )
● Cost/Day: 0,4 EUR ( 0.00 LBP )
● Cost/Month: 12 EUR ( 220,560.60 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,3186 BHD ( 0.00 LBP )
● Cost/Day: 0,64 BHD ( 0.00 LBP )
● Cost/Month: 19,2 BHD ( 762,294.63 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,3186 BHD ( 0.00 LBP )
● Cost/Day: 0,32 BHD ( 0.00 LBP )
● Cost/Month: 9,6 BHD ( 361,086.93 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,3186 BHD ( 0.00 LBP )
● Cost/Day: 0,32 BHD ( 0.00 LBP )
● Cost/Month: 9,6 BHD ( 361,086.93 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 220,560.60 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 110,280.30 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 110,280.30 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Cost/Day: 1,68 TRY ( 1,920.69 LBP )
● Cost/Month: 50,4 TRY ( 96,034.50 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Cost/Day: 0,84 TRY ( 0.00 LBP )
● Cost/Month: 25,2 TRY ( 48,017.25 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Cost/Day: 0,84 TRY ( 0.00 LBP )
● Cost/Month: 25,2 TRY ( 48,017.25 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,164 EUR ( 0.00 LBP )
● Cost/Day: 0,33 EUR ( 0.00 LBP )
● Cost/Month: 9,9 EUR ( 165,420.45 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,164 EUR ( 0.00 LBP )
● Cost/Day: 0,16 EUR ( 0.00 LBP )
● Cost/Month: 4,8 EUR ( 73,520.20 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,164 EUR ( 0.00 LBP )
● Cost/Day: 0,16 EUR ( 0.00 LBP )
● Cost/Month: 4,8 EUR ( 73,520.20 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,3639 EUR ( 0.00 LBP )
● Cost/Day: 0,73 EUR ( 0.00 LBP )
● Cost/Month: 21,9 EUR ( 385,981.05 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,3639 EUR ( 0.00 LBP )
● Cost/Day: 0,36 EUR ( 0.00 LBP )
● Cost/Month: 10,8 EUR ( 183,800.50 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,3639 EUR ( 0.00 LBP )
● Cost/Day: 0,36 EUR ( 0.00 LBP )
● Cost/Month: 10,8 EUR ( 183,800.50 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2077 JOD ( 0.00 LBP )
● Cost/Day: 0,42 JOD ( 0.00 LBP )
● Cost/Month: 12,6 JOD ( 256,082.28 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2077 JOD ( 0.00 LBP )
● Cost/Day: 0,21 JOD ( 0.00 LBP )
● Cost/Month: 6,3 JOD ( 128,041.14 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2077 JOD ( 0.00 LBP )
● Cost/Day: 0,21 JOD ( 0.00 LBP )
● Cost/Month: 6,3 JOD ( 128,041.14 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2721 KWD ( 0.00 LBP )
● Cost/Day: 0,54 KWD ( 0.00 LBP )
● Cost/Month: 16,2 KWD ( 793,121.28 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2721 KWD ( 0.00 LBP )
● Cost/Day: 0,27 KWD ( 0.00 LBP )
● Cost/Month: 8,1 KWD ( 396,560.64 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2721 KWD ( 0.00 LBP )
● Cost/Day: 0,27 KWD ( 0.00 LBP )
● Cost/Month: 8,1 KWD ( 396,560.64 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,1239 EUR ( 0.00 LBP )
● Cost/Day: 0,25 EUR ( 0.00 LBP )
● Cost/Month: 7,5 EUR ( 128,660.35 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,1239 EUR ( 0.00 LBP )
● Cost/Day: 0,12 EUR ( 0.00 LBP )
● Cost/Month: 3,6 EUR ( 55,140.15 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,1239 EUR ( 0.00 LBP )
● Cost/Day: 0,12 EUR ( 0.00 LBP )
● Cost/Month: 3,6 EUR ( 55,140.15 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,3493 OMR ( 0.00 LBP )
● Cost/Day: 0,7 OMR ( 0.00 LBP )
● Cost/Month: 21 OMR ( 825,310.50 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,3493 OMR ( 0.00 LBP )
● Cost/Day: 0,35 OMR ( 0.00 LBP )
● Cost/Month: 10,5 OMR ( 393,005.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,3493 OMR ( 0.00 LBP )
● Cost/Day: 0,35 OMR ( 0.00 LBP )
● Cost/Month: 10,5 OMR ( 393,005.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2721 EUR ( 0.00 LBP )
● Cost/Day: 0,54 EUR ( 0.00 LBP )
● Cost/Month: 16,2 EUR ( 294,080.80 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2721 EUR ( 0.00 LBP )
● Cost/Day: 0,27 EUR ( 0.00 LBP )
● Cost/Month: 8,1 EUR ( 147,040.40 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2721 EUR ( 0.00 LBP )
● Cost/Day: 0,27 EUR ( 0.00 LBP )
● Cost/Month: 8,1 EUR ( 147,040.40 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,462 EUR ( 0.00 LBP )
● Cost/Day: 0,92 EUR ( 0.00 LBP )
● Cost/Month: 27,6 EUR ( 496,261.35 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,462 EUR ( 0.00 LBP )
● Cost/Day: 0,46 EUR ( 0.00 LBP )
● Cost/Month: 13,8 EUR ( 238,940.65 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,462 EUR ( 0.00 LBP )
● Cost/Day: 0,46 EUR ( 0.00 LBP )
● Cost/Month: 13,8 EUR ( 238,940.65 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 3,1607 TND ( 0.00 LBP )
● Cost/Day: 6,32 TND ( 0.00 LBP )
● Cost/Month: 189,6 TND ( 0.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 3,1607 TND ( 0.00 LBP )
● Cost/Day: 3,16 TND ( 0.00 LBP )
● Cost/Month: 94,8 TND ( 0.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 3,1607 TND ( 0.00 LBP )
● Cost/Day: 3,16 TND ( 0.00 LBP )
● Cost/Month: 94,8 TND ( 0.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info